N/A N=46 Shockwave, Photobiomodulation, and Physical Therapy for Achilles Tendinopathy
Achilles Tendinopathy
Primary: Victorian Institute of Sports Assessment - Achilles (VISA-A) — 37.55; 43.82; 36.08; 46.92 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=46 Achilles Pain Block
Achilles Tendon Pain
Primary: Central Sensitization — 463.5; 383.6; 425.7; 358.0 kilopascal — p=0.44
N/A N=42 Evaluation of the Effectiveness of Extracorporeal Shockwave Therapy in Patients With Patellar Tendinopathy on Its Micromorphology
Patellar Tendinopathy
Primary: Change in Peak Spatial Frequency Radius at the Site of Pathology — 2.119; 2.234 mm
Phase 2 N=96 Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy
Tendinopathy
Primary: The Western Ontario Rotator Cuff (WORC) Patient Reported Outcome (PRO) Score at Week 14 in All Patients - Statistical Analysis Results of Total WORC Scores at Week 14…
N/A N=47 Evaluation of the Course and Effectiveness of Conservative Therapy in Patients With Achilles Tendinopathy
Achilles Tendinopathy
Primary: Peak Spatial Frequency Radius at the Site of Pathology — 2.180; 2.146; 2.194; 2.184 mm^-1
Phase 2 N=29 Platelet-Rich Plasma Therapy for Patellar Tendinopathy
Patellar Tendinitis
Primary: Change in Measure of Pain Level: VISA-P Score — 32.2; 46.3; 43.2; 52.5 score on a scale
N/A N=66 Tendinopathy Education on the Achilles
Achilles Tendinopathy
Primary: Pain (Aim 1) — 4.9; 5.2; 1.8; 1.5 units on a scale
N/A N=18 Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy
Achilles Tendinopathy
Primary: Change in Cross-sectional Area at the Place of Maximum Tendon Width — 0.8; 0.76; 0.78; 0.69 cm^2 — p=0.722
N/A N=46 Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy
Achilles Tendinopathy
Primary: Calf Raises Performed to Fatigue and Inability to Continue — 3; 8; 5 Calf raises
Phase 3 N=62 Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy
Tendinopathy
Primary: Change From Baseline in the Western Ontario Rotator Cuff (WORC) Patient Reported Outcome (PRO) Percentage Score at Week 24 — 55.7; 46.8 Score on a Scale
N/A N=47 Evaluation of the Efficacy of the Use MD Tissue Collagen Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS)
Greater Trochanteric Pain Syndrome · GTPS - Greater Trochanteric Pain Syndrome · Tendon Disorder
Primary: Change in NRS (Numerical Rating Scale) Pain Score From Baseline (Week 0) to Week 10 — 4.7 NRS Pain Score (range 0-10; higher score
N/A N=24 High Energy Density Pulse Electromagnetic Field for Patients With Rotator Cuff Tendinopathy
Rotator Cuff Tendinosis
Primary: Change in Pain Visual Analogue Scale(VAS) — 5.91; 5.90; 4.73; 4.60 score on a scale
N/A N=34 Effect of Dynamic Taping on Landing Biomechanics in Athletes With Symptoms of Patellar Tendinopathy
Biomechanical Phenomena
Primary: Hip Flexion Angles — 86.59; 73.65 degrees — p=0.047
Phase 4 N=44 Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection
Tendinopathy · Adrenal Insufficiency
Primary: Functional Improvement Measured According to Percentage Change in Constant Score — 99; 95 percentage of improvement Constant score
N/A N=78 Study of 25% Dextrose Injections in Shoulder Ligaments and Tendons to Promote Their Healing
Rotator Cuff Tendinitis
Primary: Visual Analog Pain Scale 0= no Pain 10 = Maximum Pain — 7.3; 6.9; 6.9 units on a scale